[1]
Dumanskiy, Y. et al. 2023. The Kі-67 marker for assessing the effectiveness of systemic or regional neoadjuvant polychemotherapy in patients with locally advanced breast cancer. Experimental Oncology. 41, 2 (Jun. 2023), 176–178. DOI:https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-2.13303.